崩漏是妇科常见病、多发病,也是临床疑难急重病,西医学称为异常子宫出血(abnormal uterine bleeding, AUB),其发生机理仍有待进一步研究。快速止血是崩漏临床主要诉求之一,而西医止血措施存在不足与局限,故寻求安全、有效的替代或联合...崩漏是妇科常见病、多发病,也是临床疑难急重病,西医学称为异常子宫出血(abnormal uterine bleeding, AUB),其发生机理仍有待进一步研究。快速止血是崩漏临床主要诉求之一,而西医止血措施存在不足与局限,故寻求安全、有效的替代或联合治疗药物是临床关注的重点环节。中医认为崩漏病机主要为“虚、热、瘀”单独或复合成因致使冲任不固,塞流结合澄源是主要治疗原则,且大量研究显示中医药治疗崩漏出血期疗效确切、安全可靠、复发率低,临床优势明显,现就中医药治疗崩漏出血期的研究进展作一综述。Metrorrhagia and menorrhagia are common, frequently-occurring diseases in gynecology, and also clinically difficult, critical and urgent diseases. In Western medicine, it is called abnormal uterine bleeding (AUB), and its pathogenesis still needs further study. Rapid hemostasis is one of the main clinical demands for metrorrhagia and menorrhagia. However, there are deficiencies and limitations in Western medical hemostasis measures. Therefore, seeking safe and effective alternative or combined therapeutic drugs is a key focus in clinical practice. Traditional Chinese medicine (TCM) believes that the pathogenesis of metrorrhagia and menorrhagia is mainly due to “deficiency, heat, and stasis”, either alone or in combination, which leads to the insecurity of the thoroughfare and conception vessels. The main treatment principles are “stopping bleeding” combined with “treating the root cause”. A large number of studies have shown that TCM treatment of the bleeding phase of metrorrhagia and menorrhagia has definite curative effects, is safe and reliable, has a low recurrence rate, and has obvious clinical advantages. This paper reviews the research progress on the treatment of the bleeding phase of metrorrhagia and menorrhagia with TCM.展开更多
文摘崩漏是妇科常见病、多发病,也是临床疑难急重病,西医学称为异常子宫出血(abnormal uterine bleeding, AUB),其发生机理仍有待进一步研究。快速止血是崩漏临床主要诉求之一,而西医止血措施存在不足与局限,故寻求安全、有效的替代或联合治疗药物是临床关注的重点环节。中医认为崩漏病机主要为“虚、热、瘀”单独或复合成因致使冲任不固,塞流结合澄源是主要治疗原则,且大量研究显示中医药治疗崩漏出血期疗效确切、安全可靠、复发率低,临床优势明显,现就中医药治疗崩漏出血期的研究进展作一综述。Metrorrhagia and menorrhagia are common, frequently-occurring diseases in gynecology, and also clinically difficult, critical and urgent diseases. In Western medicine, it is called abnormal uterine bleeding (AUB), and its pathogenesis still needs further study. Rapid hemostasis is one of the main clinical demands for metrorrhagia and menorrhagia. However, there are deficiencies and limitations in Western medical hemostasis measures. Therefore, seeking safe and effective alternative or combined therapeutic drugs is a key focus in clinical practice. Traditional Chinese medicine (TCM) believes that the pathogenesis of metrorrhagia and menorrhagia is mainly due to “deficiency, heat, and stasis”, either alone or in combination, which leads to the insecurity of the thoroughfare and conception vessels. The main treatment principles are “stopping bleeding” combined with “treating the root cause”. A large number of studies have shown that TCM treatment of the bleeding phase of metrorrhagia and menorrhagia has definite curative effects, is safe and reliable, has a low recurrence rate, and has obvious clinical advantages. This paper reviews the research progress on the treatment of the bleeding phase of metrorrhagia and menorrhagia with TCM.
